Evidence map›Paper›PMID 31626649›Full record

ArticlePloS one2019

Liquorice ingestion attenuates vasodilatation via exogenous nitric oxide donor but not via β2-adrenoceptor stimulation.

Elina J Hautaniemi, Antti J Tikkakoski, Arttu Eräranta, Mika Kähönen, Esa Hämäläinen, Ursula Turpeinen, Heini Huhtala, Jukka Mustonen, Ilkka H Pörsti

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01742702 (Non-Invasive HaemoDYNAMICs in Primary and Secondary Hypertension), which is not on this map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01742702 unknown statusnot on this map

Non-Invasive HaemoDYNAMICs in Primary and Secondary Hypertension: the DYNAMIC-study

TypeobservationalSponsorTampere UniversityRan2006 to 2025Enrolled2,000ConditionsPrimary Hypertension, Secondary Hypertension, Aortic Stenosis, Renal InsufficiencyArmsNitroglycerin 0.25 mg (single dose, no longer given since January 2017), Salbutamol 400 µg (single dose, no longer given since January 2017), L-arginine (10 min infusion, no longer given since January 2017), Liquorice (2 weeks, glycyrrhizin 290-370 mg daily, no longer given since 2012), Small milk casein-derived polypeptides (12 weeks daily, recordings completed 2011)
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Elina J HautaniemiFaculty of Medicine and Health Technology, Tampere University, Tampere, Finland.ORCID 0000-0003-3699-8960
Antti J TikkakoskiFaculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Arttu ErärantaFaculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Mika KähönenFaculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Esa HämäläinenHUSLAB, Helsinki University Hospital, Helsinki, Finland.
Ursula TurpeinenHUSLAB, Helsinki University Hospital, Helsinki, Finland.
Heini HuhtalaFaculty of Social Sciences, Tampere University, Tampere, Finland.
Jukka MustonenFaculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Ilkka H PörstiFaculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Tampere University · FIHelsinki University Hospital · FIUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We examined the effect of liquorice ingestion on haemodynamic responses to exogenous nitric oxide donor (nitroglycerin) and β2-adrenoceptor agonist (salbutamol), and 11β-hydroxysteroid dehydrogenase activity, in 21 volunteers and 21 reference subjects. Haemodynamic data was captured before and after sublingual nitroglycerin (0.25 mg) and inhaled salbutamol (400 μg) during orthostatic challenge utilising radial pulse wave analysis and whole-body impedance cardiography. The recordings were performed at baseline and following two weeks of liquorice intake (290-370 mg/d glycyrrhizin). Urinary cortisone and cortisol metabolites were examined. Liquorice intake elevated aortic systolic and diastolic blood pressure and systemic vascular resistance when compared with the reference group. Following research drug administration the liquorice-induced increase in systemic vascular resistance was observed in the presence of nitroglycerin (p<0.05) but no longer in the presence of salbutamol. Liquorice ingestion decreased cardiac chronotropic response to upright posture (p = 0.032) in unadjusted analysis, but when adjusted for age and sex the difference in the upright change in heart rate was no longer significant. The urinary cortisone to cortisol metabolite ratio decreased from 0.70 to 0.31 (p<0.001) after liquorice intake indicating significant inhibition of the 11β-hydroxysteroid dehydrogenase type 2. In the reference group the haemodynamic variables remained virtually unchanged. These results suggest that liquorice exposure impaired vasodilatation in vivo that was induced by exogenous nitric oxide donor but not that induced by β2-adrenoceptor stimulation. Trial registration: EU Clinical Trials Register 2006-002065-39 ClinicalTrials.gov NCT01742702.

Indexed as

EatingVasodilationAdrenergic beta-2 Receptor AgonistsAdultAlbuterolBiomarkersBlood PressureCardiography, ImpedanceFemaleGlycyrrhizaHemodynamicsHumansMaleMiddle AgedNitric Oxide DonorsPulse Wave AnalysisAdrenergic beta-2 Receptor AgonistsAlbuterolBiomarkersNitric Oxide DonorsReceptors, Adrenergic, beta-2

Identifiers

PMID31626649
PMCPMC6799927
OpenAlexW2980330555

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.